CYTOVIA Trademark
Trademark Overview
On Monday, July 19, 2021, a trademark application was filed for CYTOVIA with the United States Patent and Trademark Office. The USPTO has given the CYTOVIA trademark a serial number of 90836122. The federal status of this trademark filing is OPPOSITION PENDING as of Friday, November 11, 2022. This trademark is owned by Cytovia Therapeutics, Inc.. The CYTOVIA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in natural killer cell therapies
Research and development in the field of immunotherapy; research and development in the field of cancer treatment; research and development in the field of natural killer cells
General Information
Serial Number | 90836122 |
Word Mark | CYTOVIA |
Filing Date | Monday, July 19, 2021 |
Status | 774 - OPPOSITION PENDING |
Status Date | Friday, November 11, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, May 17, 2022 |
Trademark Statements
Goods and Services | Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in natural killer cell therapies |
Goods and Services | Research and development in the field of immunotherapy; research and development in the field of cancer treatment; research and development in the field of natural killer cells |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, September 21, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, September 21, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Cytovia Therapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Aventura, FL 33180 |
Party Name | Cytovia Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Aventura, FL 33180 |
Trademark Events
Event Date | Event Description |
Tuesday, September 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, July 22, 2021 | NEW APPLICATION ENTERED |
Monday, April 11, 2022 | ASSIGNED TO EXAMINER |
Wednesday, April 13, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, May 17, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, April 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, May 17, 2022 | PUBLISHED FOR OPPOSITION |
Thursday, May 26, 2022 | LETTER OF PROTEST EVIDENCE FORWARDED |
Thursday, May 26, 2022 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
Thursday, June 16, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
Friday, November 11, 2022 | OPPOSITION INSTITUTED NO. 999999 |